TABLE 4.
Nucleotide sequence and drug resistance mutation identities between paired DBS and plasma specimens
Group | n | % nucleotide sequence identity |
% DR position identity |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Minimum | 25% percentile | Median | 75% percentile | Maximum | Mean | Minimum | 25% percentile | Median | 75% percentile | Maximum | Mean | ||
1 | 99 | 95.8 | 98.95 | 99.52 | 99.81 | 100 | 99.31 | 91.23 | 98.25 | 100 | 100 | 100 | 99.36 |
2 | 98 | 97.33 | 98.95 | 99.43a | 99.71 | 100 | 99.18 | 94.74 | 98.25 | 100 | 100 | 100 | 99.25 |
3 | 94 | 96.08 | 98.57 | 99.24a | 99.62 | 100 | 99.06 | 89.47 | 98.25 | 100 | 100 | 100 | 99.24 |
4 | 90 | 96.85 | 98.64 | 99.14a | 99.62 | 100 | 99.04 | 91.23 | 98.25 | 100 | 100 | 100 | 99.18 |
5 | 78 | 93.7 | 98.47 | 99.09a | 99.52 | 100 | 98.96 | 94.74 | 98.25 | 100 | 100 | 100 | 99.3 |
Wilcoxon matched-pairs signed-rank test P < 0.0001 versus group 1.